Medidas de condutividade A.C. e constante dielétrica na perovskita dupla Ca1.2 La0.8 FeIrO6

This work introduces the results from the performing of impedance spectroscopy on the transition metals oxide Ca1.2La0.8FeIrO6. It was sought to understand the behavior of one sample from its impedance spectra for different AC voltages and temperature values and if an applied external magnetic field at room temperature would cause some change on it. The results revealed that the Ca1.2La0.8FeIrO6 at high temperatures shows conductive and inductive behavior and that the resistance increases with frequency, phenomenon known as Kelvin effect. At 150 K, the spectrum real part no longer consists with the theoretical prediction of Kelvin effect, starting to be influenced by the utilized voltages, condition that inexists on theory. At low temperatures (10, 20, 30 K) it was observed resistive and capacitive behavior, being possible on these conditions, associate to the sample a paralel RC circuit in series with a contact resistance with a fitting from the ZSim software. This fitting allowed the obtaining of capacitance, DC resistance and contact resistance values. The application of a 700G magnetic field at room temperature didn't cause changes on the spectra

Análises celulares e moleculares dos efeitos do peptídeo vasoativo angiotensina-(1-7) no processo tumoral pulmonar e a atuação do microrna 21-5P

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Post-translational modification of the RhoGTPase activating protein 21, ARHGAP21, by SUMO2/3

ARHGAP21 is a 217 kDa RhoGAP protein shown to modulate cell migration through the control of Cdc42 and FAK activities. In the present work a 250 kDa-ARHGAP21 was identified by mass spectrometry. This modified form is differentially expressed among cell lines and human primary cells. Co-immunoprecipitations and in vitro SUMOylation confirmed ARHGAP21 specific modification by SUMO2/3 and mapped the SUMOylation site to ARHGAP21 lysine K1443. Immunofluorescence staining revealed that ARHGAP21 co-localizes with SUMO2/3 in the cytoplasm and membrane compartments. Interestingly, our results suggest that ARHGAP21 SUMOylation may be related to cell proliferation. Therefore, SUMOylation of ARHGAP21 may represent a way of guiding its function. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

alpha,beta-Unsaturated Diazoketones as Platforms in the Asymmetric Synthesis of Hydroxylated Alkaloids. Total Synthesis of 1-Deoxy-8,8a-diepicastanospermine and 1,6-Dideoxyepicastanospermine and Formal Synthesis of Pumiliotoxin 251D

A versatile and concise approach for the stereoselective synthesis of mono-, di-, and trihydroxylated indolizidines is presented in four to six steps from Cbz-prolinal and a diazophosphonate. The key steps involved a Wolff rearrangement, followed by a stereoselective dihydroxylation/epoxidation reaction, from an alpha,beta-unsaturated diazoketone. The strategy also permits extension to the synthesis of many natural hydroxylated indolizidine alkaloids as demonstrated in the formal synthesis of pumiliotoxin 251D.

Transmission of Human Herpesvirus Type 8 Infection Within Families in American Indigenous Populations From the Brazilian Amazon

Background. The intrafamilial dynamics of endemic infection with human herpesvirus type 8 (HHV-8) in Amerindian populations is unknown. Methods. Serum samples were obtained from 517 Amerindians and tested for HHV-8 anti-latent nuclear antigen (anti-LANA) and antilytic antibodies by immunofluorescence assays. Logistic regression and mixed logistic models were used to estimate the odds of being HHV-8 seropositive among intrafamilial pairs. Results. HHV-8 seroprevalence by either assay was 75.4% (95% confidence interval [CI]: 71.5%-79.1%), and it was age-dependent (P-trend<.001). Familial dependence in HHV-8 seroprevalence by either assay was found between mother-offspring (odds ratio [OR], 5.44; 95% CI: 1.62-18.28) and siblings aged >= 10 years (OR 4.42, 95% CI: 1.70-11.45) or siblings in close age range (<5 years difference) (OR 3.37, 95% CI: 1.21-9.40), or in families with large (>4) number of siblings (OR, 3.20, 95% CI: 1.33-7.67). In separate analyses by serological assay, there was strong dependence in mother-offspring (OR 8.94, 95% CI: 2.94-27.23) and sibling pairs aged >= 10 years (OR, 11.91, 95% CI: 2.23-63.64) measured by LANA but not lytic antibodies. Conclusions. This pattern of familial dependence suggests that, in this endemic population, HHV-8 transmission mainly occurs from mother to offspring and between close siblings during early childhood, probably via saliva. The mother to offspring dependence was derived chiefly from anti-LANA antibodies.

Pathogen levels and clinical response to periodontal treatment in patients with Interleukin 8 haplotypes

The aim of this study was to investigate the effect of non-surgical treatment of periodontitis on the levels of periodontopathogens and clinical parameters in patients with different genetic backgrounds produced by polymorphisms in the Interleukin (IL8) gene. Thirty patients grouped according to IL8 ATC/TTC or AGT/TTC haplotypes were submitted to non-surgical periodontal treatment. Levels of Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola were determined in 240 subgingival plaque samples by qPCR. The association between IL8 haplotypes and the levels of periodontopathogens and clinical parameters was investigated by multilevel analysis accounting for the clustering of diseased sites analyzed within patients. It was observed that neither levels of periodontopathogens nor non-surgical treatment was associated with the IL8 haplotype. The clinical parameters after periodontal treatment were similar in diseased and healthy sites, independently of the IL8 haplotype. Nonetheless, in the same period, diseased sites of AGT/TTC patients harbored higher levels of P. gingivalis, T. denticola, T. forsythia, and red complex than those of ATC/TTC patients. However, the non-surgical periodontal therapy decreased the levels of these periodontopathogens and of the tested clinical parameters of diseased sites in both groups. Non-surgical therapy is equally effective in improving clinical parameters and decreasing the levels of periodontopathogens, independent of the genotype groups produced by the IL8 haplotype.

Analisi dello spettro di massa invariante j/psi pi+ pi- in collisioni p-p a sqrt(s) = 8 tev con il rivelatore cms

In questo lavoro di tesi è stato studiato lo spettro di massa invariante del sistema J/psi pi+ pi-, m(J/psi pi+ pi-), in collisioni protone-protone a LHC, con energia nel centro di massa sqrt(s)) pari a 8 TeV, alla ricerca di nuovi stati adronici. Lo studio è stato effettuato su un campione di dati raccolti da CMS in tutto il 2012, corrispondente ad una luminosità integrata di 18.6 fb-1. Lo spettro di massa invariante m(J/psi pi+ pi-), è stato ricostruito selezionando gli eventi J/psi->mu+ mu- associati a due tracce cariche di segno opposto, assunte essere pioni, provenienti da uno stesso vertice di interazione. Nonostante l'alta statistica a disposizione e l'ampia regione di massa invariante tra 3.6 e 6.0 GeV/c^2 osservata, sono state individuate solo risonanze già note: la risonanza psi(2S) del charmonio, lo stato X(3872) ed una struttura più complessa nella regione attorno a 5 GeV/c^2, che è caratteristica della massa dei mesoni contenenti il quark beauty (mesoni B). Al fine di identificare la natura di tale struttura, è stato necessario ottenere un campione di eventi arricchito in adroni B. È stata effettuata una selezione basata sull'elevata lunghezza di decadimento, che riflette la caratteristica degli adroni B di avere una vita media relativamente lunga (ordine dei picosecondi) rispetto ad altri adroni. Dal campione così ripulito, è stato possibile distinguere tre sottostrutture nello spettro di massa invariante in esame: una a 5.36 GeV/c^2, identificata come i decadimenti B^0_s-> J/psi pi+ pi-, un'altra a 5.28 GeV/c^2 come i candidati B^0-> J/psi pi+ pi- e un'ultima allargata tra 5.1 e 5.2 GeV/c^2 data da effetti di riflessione degli scambi tra pioni e kaoni. Quest'ultima struttura è stata identificata come totalmente costituita di una combinazione di eventi B^0-> J/psi K+ pi- e B^0_s-> J/psi K+ K-.

Luminosity determination for the measurement of the proton-proton total cross section at 8 TeV in the Atlas experiment

La sezione d’urto totale adronica gioca un ruolo fondamentale nel programma di fisica di LHC. Un calcolo di questo parametro, fondamentale nell’ambito della teoria delle interazioni forti, non é possibile a causa dell’inapplicabilità dell’approccio perturbativo. Nonostante ciò, la sezione d’urto può essere stimata, o quanto meno le può essere dato un limite, grazie ad un certo numero di relazioni, come ad esempio il Teorema Ottico. In questo contesto, il detector ALFA (An Absolute Luminosity For ATLAS) sfrutta il Teorema Ottico per determinare la sezione d’urto totale misurando il rate di eventi elastici nella direzione forward. Un tale approccio richiede un metodo accurato di misura della luminosità in condizioni sperimentali difficoltose, caratterizzate da valori di luminosità istantanea inferiore fino a 7 ordini di grandezza rispetto alle normali condizioni di LHC. Lo scopo di questa tesi è la determinazione della luminosità integrata di due run ad alto β*, utilizzando diversi algoritmi di tipo Event-Counting dei detector BCM e LUCID. Particolare attenzione è stata riservata alla sottrazione del fondo e allo studio delle in- certezze sistematiche. I valori di luminosità integrata ottenuti sono L = 498.55 ± 0.31 (stat) ± 16.23 (sys) μb^(-1) and L = 21.93 ± 0.07 (stat) ± 0.79 (sys) μb^(-1), rispettivamente per i due run. Tali saranno forniti alla comunità di fisica che si occupa della misura delle sezioni d’urto protone-protone, elastica e totale. Nel Run II di LHC, la sezione d’urto totale protone-protone sarà stimata con un’energia nel centro di massa di 13 TeV per capire meglio la sua dipendenza dall’energia in un simile regime. Gli strumenti utilizzati e l’esperienza acquisita in questa tesi saranno fondamentali per questo scopo.

Humoral response to 2 inactivated bluetongue virus serotype-8 vaccines in South American camelids

BACKGROUND: Bluetongue virus serotype 8 (BTV-8) has caused disease in domestic ruminants in several countries of northern Europe since 2006. In 2008 a mass-vaccination program was launched in most affected countries using whole virus inactivated vaccines. OBJECTIVE: To evaluate 2 inactivated vaccines (Bovilis BTV 8; BTVPUR AlSap8) for immunogenicity and safety against BTV-8 in South American camelids (SAC) in a field trial. ANIMALS: Forty-two SAC (25 Alpacas, 17 Llamas) aged between 1 and 16 years. METHODS: The animals were vaccinated twice at intervals of 21 days. They were observed clinically for adverse local, systemic, or both reactions throughout the trial. Blood samples collected on days 0, 14, 21, 43, and 156 after vaccination were tested for the presence of BTV-8 virus by real time-polymerase chain reaction and of specific antibodies by competitive ELISA and a serum neutralization test. RESULTS: All vaccinated animals developed antibodies to BTV-8 after the 2nd administration of the vaccine. No adverse effects were observed except for moderate local swellings at the injection site, which disappeared within 21 days. Slightly increased body temperatures were only observed in the first 2 days after vaccination. The BTV was not detected in any of the samples analyzed. CONCLUSIONS AND CLINICAL IMPORTANCE: The administration of the 2 inactivated commercial vaccines was safe and induced seroconversion against BTV-8 in all vaccinated animals. The results of this study suggest that 2 doses injected 3 weeks apart is a suitable vaccination regimen for SAC.

Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes

AIMS: We investigated whether myeloid-related protein 8/14 complex (MRP8/14) expressed by infiltrating monocytes and granulocytes may represent a mediator and early biomarker of acute coronary syndromes (ACS). METHODS AND RESULTS: Immunohistochemistry of coronary thrombi was done in 41 ACS patients. Subsequently, levels of MRP8/14 were assessed systemically in 75 patients with ACS and culprit lesions, with stable coronary artery disease (CAD), or with normal coronary arteries. In a subset of patients, MRP8/14 was measured systemically and at the site of coronary occlusion. Macrophages and granulocytes, but not platelets stained positive for MRP8/14 in 76% of 41 thrombi patients. In ACS, local MRP8/14 levels [22.0 (16.2-41.5) mg/L] were increased when compared with systemic levels [13.4 (8.1-14.7) mg/L, P = 0.03]. Systemic levels of MRP8/14 were markedly elevated [15.1 (12.1-21.8) mg/L, P = 0.001] in ACS when compared with stable CAD [4.6 (3.5-7.1) mg/L] or normals [4.8 (4.0-6.3) mg/L]. Using a cut-off level of 8 mg/L, MRP8/14 but not myoglobin or troponin, identified ACS presenting within 3 h from symptom onset. CONCLUSION: In ACS, MRP8/14 is markedly expressed at the site of coronary occlusion by invading phagocytes. The occurrence of elevated MRP8/14 in the systemic circulation prior to markers of myocardial necrosis makes it a prime candidate for the detection of unstable plaques and management of ACS.